Glaxo (GSK), Theravance (THRX) Receive EC Marketing Approval for RELVAR ELLIPTA
Tweet Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (Nasdaq: THRX) announced that the European Commission has granted marketing authorisation for RELVAR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
